In the competitive world of biopharmaceutical development, successfully navigating clinical trials to regulatory approval requires more than scientific excellence; it demands strategic mastery of licensing and compliance frameworks. Richard Katz, MD, MHA, brings decades of healthcare administration expertise to help organizations transform promising therapies into approved, market-ready treatments.